PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home » Alcohol-related Psychosis



Psychiatric Times. Vol. 27 No. 1
Pages: 1  2  
Previous
NEWS 

Alert to the Research Community—Be Prepared to Weigh In on DSM-V

By Allen Frances, MD | January 7, 2010

Dr Frances was the chair of the DSM-IV Task Force and of the department of psychiatry at Duke University School of Medicine, Durham, NC. He is currently professor emeritus at Duke.


What harm can DSM-V do?

Elsewhere, I have outlined the 3 harmful unintended consequences that emerged unexpectedly from DSM-IV4-6: namely, a contribution to the false epidemics of autism and attention-deficit disorder and a forensic disaster that has led to the inappropriate psychiatric commitment of sexually violent offenders. These unpleasant surprises occurred despite the fact that DSM-IV was stubbornly unambitious, discouraged all changes, required extensive empirical documentation, and was reviewed widely by the field at large and by numerous advisors. The risks of unintended consequences from an ambitious, secretive, and poorly organized DSM-V are numerous and significant. My focus here is only on the ways in which DSM-V may be costly and risky to the research enterprise.

The criteria sets for the most widely studied disorders have been quite stable since the publication of DSM-III in 1980 and since the publication of the Research Diagnostic Criteria in 1978. These DSM criteria sets served as the foundation of the structured and semi-structured interview instruments widely used in all clinical and epidemiological research. Whenever DSM-V makes a change in a criteria set, this necessitates a change in the instruments used to assess that diagnosis.

Aside from the considerable cost and inconvenience occasioned by them, such changes have the potential to break the highly desirable continuity between the past, ongoing research, and future research findings. The new diagnostic criteria will have untested psychometric performance characteristics and may result in a very different definition of “caseness.” This would make it extremely difficult to interpret differences in findings across time, because the studies will have been done using different criteria. This “apples and oranges” problem will greatly complicate the already difficult interpretation of the often radically different rates of mental disorder determined by different epidemiological studies.7-10

A prime example of how far the ambitions of the DSM-V Task Force has exceeded its grasp is its goal to develop and market a set of new interviewing instruments to be used in conjunction with DSM-V.3 While the commercial motivation is understandable, the disruption of the continuity of the methods would be unfortunate and the costs of switching to a new system of instruments would be prohibitive and wasteful. Moreover, nothing in the work to date by the DSM-V Task Force inspires confidence in its ability to produce and test useful new interviewing instruments and it would seem to have its hands more than full producing DSM-V itself without needing other distractions.

As I have argued elsewhere, there are serious risks in including a number of prodromal and subthreshold conditions as official diagnostic categories in DSM-V.11-13 The most appealing subthreshold conditions (minor depression, mixed anxiety depression, minor cognitive disorder, and prepsychotic disorder) are all characterized by nonspecific symptoms that are present at extremely high frequencies in the general population. These proposed “disorders” might well become among the most common diagnoses in the general population—particularly once they are helped along by drug company marketing—resulting in excessive use of medications that often have serious long-term complications associated with weight gain. Early case finding is a wonderful goal, but it requires a happy combination of a specific diagnostic test and a safe intervention. Instead, we would now have the peculiarly unhappy combination of a wildly false-positive set of criteria coupled with potentially dangerous interventions.

Prospective epidemiological research suggests that DSM-IV is already quite over-inclusive.14 In addition widening the net would go even further in both medicalizing normality and trivializing psychiatric diagnoses. Altogether, in my view, the costs and risks of the subthreshold diagnoses far outweigh any possible current gains.

What can be done to save DSM-V from itself?

The DSM-V process would not be in its current state if it had been self-correcting and/or open to external suggestions. Influencing its direction now will not be easy but is certainly not impossible. It will require a sustained external pressure that the research community is well positioned to apply.

Optimism that DSM-V can be saved from itself springs from the fact that external pressure has already resulted in the following improvements, however reluctantly made:

1. Appointment by the American Psychiatric Association (APA) Board of Trustees of an oversight committee to monitor the work on DSM-V

2. Postponement of field trials until after options have been posted and reviewed

3. Reduction of hype about a “paradigm shift”

4. Increased recognition of the value of caution

5. Likely postponement of the publication date of DSM-V to May 2013.

There are 3 levers of pressure that the research community can exert to affect a more open, empirically based, and accurate DSM-V:

• Most immediately, starting in January, researchers can each have a valuable correcting role by pointing out the specific problems in their areas that will be caused by the various DSM-V suggestions for change.

• Within the APA itself, the most relevant components are the Council on Research and Quality and the newly appointed oversight committee—which includes prominent spokespeople for the research community.

• The APA will be exquisitely sensitive to pressure from the research community—most especially if it comes from the NIMH, National Institute of Drug Abuse, and/or National Institute of Alcohol(Drug information on alcohol) Abuse and Alcoholism, but also from other relevant research-oriented organizations within psychiatry, psychology, and the neurosciences. The APA realizes that it holds the franchise to publish DSM only by historical accident and that this is easily revocable if enough interested organizations lose confidence in its competence and its ability to control the inherent conflict of interest.

Another possible contribution to DSM-V that has excited many psychiatric researchers—but which is certainly premature—is the proposal to go beyond the descriptive method used in the DSM system and instead attempt to base the classification on the exciting new findings from the revolution in neuroscience.15 This goal would certainly be highly desirable but, in my view, should not play any current role in creating the DSM-V diagnostic criteria. As an official nomenclature, DSM-V must follow behind research and include findings that are well-established and widely agreed-on.

The next 6 months are certain to be the most important in the development of DSM-V—especially because the field trials will probably not measure impact on rates and are thus likely not to be very informative. Researchers should carefully review DSM-V drafts as they emerge and make their concerns known.

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Robert Peers | November 07, 2010 2:03 AM EST

Dr Mota-Castillo and his colleagues would have few cases--if any-- of ADHD, OD, CD etc., were it not for the widespread consumption of refined seed oils in the USA, since about 1920. Vacuum deodorization of smelly cottonseed and peanut oils was invented in Savannah, Georgia, in 1899, by food oil chemist David Wesson. These oils are low in vitamin E, which results in cerebral lipid peroxidation (eg. ADHD kids exhale ethane gas, a marker of such peroxidation: B Ross, 2003). Prenatal exposure results in a typical ADHD kid, plus a forgetful, photophobic mother, who takes sunglasses everywhere she goes. The same oils cause Alzheimer's in later life. Any ADHD kid still exposed to these common salad and frying oils in their daily diet will be exhaling ethane gas, and will be clinically worse, with frontal lobe aggression and impulsiveness rarely or never seen in kids pre-1899. They are all Phineas Gage mimics, but what's been through their brain is not a tamping iron, but refined seed oil. I have seen very good results in my ADHD child cases, simply by eliminating refined seed oils from the diet, and by adding some oily fish, or fish oil capsules. No such child, in my care, has ever needed ADHD medication.

by Robert Peers | November 07, 2010 2:01 AM EST

Dr Mota-Castillo and his colleagues would have few cases--if any-- of ADHD, OD, CD etc., were it not for the widespread consumption of refined seed oils in the USA, since about 1920. Vacuum deodorization of smelly cottonseed and peanut oils was invented in Savannah, Georgia, in 1899, by food oil chemist David Wesson. These oils are low in vitamin E, which results in cerebral lipid peroxidation (eg. ADHD kids exhale ethane gas, a marker of such peroxidation: B Ross, 2003). Prenatal exposure results in a typical ADHD kid, plus a forgetful, photophobic mother, who takes sunglasses everywhere she goes. The same oils cause Alzheimer's in later life. Any ADHD kid still exposed to these common salad and frying oils in their daily diet will be exhaling ethane gas, and will be clinically worse, with frontal lobe aggression and impulsiveness rarely or never seen in kids pre-1899. They are all Phineas Gage mimics, but what's been through their brain is not a tamping iron, but refined seed oil. I have seen very good results in my ADHD child cases, simply by eliminating refined seed oils from the diet, and by adding some oily fish, or fish oil capsules. No such child, in my care, has ever needed ADHD medication.

by John Riley | July 08, 2010 4:45 PM EDT

Dr. Frances has repeatedly expressed very appropriate concerns regarding the content of the developing DSM-5. I think the more important tort, however, should be with the process. I am a graduate of the Napa State Hospital residency program, closed by decertification of the program by the Residency Review Committee some years ago. The reason our program is no longer extant was that the training was TOO DIVERSE! The plethora of adjunct training sites in the Bay Area created an embarrassment of riches, providing a breadth of experience that other programs could not match. By a similar stretch of logic, the current DSM revision task force, as stated on the DSM website, restricted input to clinicians who were not familiar with the history of the manual. They did this in order to ensure fresh input (see term limits elsewhere). We are now risking the legacy of the finest work in psychiatry from the 20th century, as this potential replacement nosologic manual careens away from the Feighner Criteria and DSM III. We need to stop and reconsider: are we pruning a manual to produce a more naturalistic grouping and naming of the entities we call psychiatric illness, or are we opening a door for relaxed rules of prescribing, as the dimensional assessments seems likely to do?

by Manuel Mota-Castillo | February 02, 2010 9:14 AM EST

 

 

            We thank Psychiatric Times and Dr. Allen Frances for making the DSM-V's development an interesting debate to follow.  However, we believe that Dr. Frances' invitation to the research community should also be extended to frontline clinicians like us, and we worry about the implicit infallibility assigned to the medical research community.

            In our view, the imminent perpetuation of several diagnostic artifacts included in DSM-IV-TR not only poses risks to the health and well-being of our patients, but also raises questions regarding the reliability of several diagnoses.  As has been noted, (1,2,3), the psychoanalytic orientation of psychiatry at the time DSM-III and DSM-IV were created generated pseudo-diagnoses that are now used by the HMOs to deny inpatient treatment.  These pseudo-diagnoses also contaminate data in expensive studies, such as the Multimodal Treatment Study of Children with ADHD (MTA) (4)

            Specifically: Oppositional-Defiant Disorder (ODD), Conduct Disorder (CD), Disruptive Disorder NOS, Borderline Personality Disorder (BPD), and Intermittent Explosive Disorder (IED) are labels that emerged as "solutions"to explain syndromes clinicians were observing in the 1970s and 80s.  We believe that, in fact, psychiatrists were encountering social anxiety, obsessions, bipolar spectrum disorders, psychosis, PTSD, phobias, and even complications of sexual abuse in children--but were discouraged by the prevailing orthodoxy from identifying these conditions by their real names.

            Today, children with defiant and aggressive behavior due to pathologically elevated mood are called "ODD with comorbid ADHD," because they are restless and inattentive. We believe these symptoms are usually due to agitated manic states.  Moreover, when these so-called "ADHD symptoms" are treated with amphetamines, the patient's condition typically worsens and may eventuate in assaultive  behavior-at which point, the patient "graduates" to the additional diagnosis of Conduct Disorder!  Worse still, the patient is then labeled "unruly" or "incorrigible" when he "refuses to change his behavior despite adequate treatment." In our collective experience, many such patients end up in Residential Treatment Centers and Juvenile Detention Centers. Sadly, we have found an abundance of such "violent kids" who are still prescribed stimulant medications while incarcerated.

            We also applaud Dr. Frances for addressing the "false epidemics of autism and attention-deficit-disorder," because we rarely see "heavy weight champions" joining the ranks of Hagop Akiskal,(5)  Charles Huffine, Andy Pumariega and a few others, who have directly defied some of the DSM's diagnostic guidelines.  

            We acknowledge that we lack randomized, controlled double-blind studies to confirm our observations-but we have many years of "eye-opening" experience that should not be ignored or considered irrelevant. Collectively, we manage the treatments of thousands of people whose lives have been transformed for the best by the diagnostic approach we advocate: avoiding the use of DSM labels like ODD, CD, BPD, and all the other "disorders" that are already explained by well-established diagnoses, for which we have effective treatments.

 

Daniel Pistone, M.D.

Manuel Mota-Castillo, M.D.

Roberto Chaveve M.D.

 

References:

1-      Mota-Castillo, M., It is Really ODD?; Psychiatric Times Vol. 21, No. 3, 2004

2-      Huffine, C., M.D. "Should the Conduct Disorder diagnosis be struck from the DSM-V?" Clinical Psychiatric News, Volume 28(4), 2000.

3-      Atkins, D.L., Pumariega, A.J., Montgomery, L., Rogers, K., Nybro, C., Jeffers, G., Sease, F. Mental Health and Incarcerated Youth: Prevalence and Nature of Psychopathology. Journal of Child and Family Studies. 8(2): 193-204, 1999.

4-      Akiskal, H., Demystifying borderline personality: critique of the concept and unorthodox reflections on its natural kinship with the bipolar spectrum. Acta Psych Scand. Psych.; 110: 401-407, 2004

5-      Jensen, P., M.D., Findings from the NIMH Multimodal Treatment of ADHD (MTA): Implications and Applications for Primary Care Providers; J. of Dev. & Behav. Ped., Vol 22, No. 1, 2001.

 





References
1. Kupfer DJ, Regier DA, Kuhl EA. On the road to DSM-V and ICD-11. Eur Arch Psychiatry Clin Neurosci. 2008;258(suppl 5):2-6.
2. Kupfer DJ, Kuhn EA, Regier DA. Research for improving diagnostic systems: consideration of factors related to later life development. Am J Geriatr Psychiatry. 2009;17:355-358.
3. Regier DA, Narrow WE, Kuhl EA, Kupfer DJ. The conceptual development of DSM-V. Am J Psychiatry. 2009;166:645-650.
4. First MB, Halon RL. Use of DSM paraphilia diagnoses in sexually violent predator commitment cases. J Am Acad Psychiatry Law.2008;36:443-454.
5. First MB, Frances A. Issues for DSM-V: unintended consequences of small changes: the case of paraphilias [published correction appears in Am J Psychiatry. 2008;165:1495]. Am J Psychiatry. 2008;165:1240-1241.
6. Frances A, Sreenivasan S, Weinberger LE. Defining mental disorder when it really counts—DSM-IV-TR and SVP/SDP statutes. J Am Acad Psychiatry Law. 2008;36:375-384.
7. Robins LN, Helzer JE, Weissman MM, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984;41:949-958.
8. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
9. Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67:247-257.
10. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-627.
11. Frances A. A warning sign on the road to DSM-V: beware of its unintended consequences. Psychiatr Times.2009;26(8):1-9.
12. Woods SW, Addington J, Cadenhead KS, et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull. 2009;35:894-908.
13. Carpenter WT. Anticipating DSM-V: should psychosis risk become a diagnostic class? Schizophr Bull. 2009;35:841-843.
14. Moffitt TE, Caspi A, Taylor A, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med. 2009 Sep 1:1-11 [Epub ahead of print].
15. Andrews G, Goldberg DP, Krueger RF, et al. Exploring the feasibility of a meta-structure for DSM-V and ICD-11: could it improve utility and validity? Psychol Med. 2009;39:1993-2000.

Follow the DSM debate
• Frances A. A warning sign on the road to DSM-V: beware of its unintended consequences. Psychiatr Times.2009;26(8):1-9.
• Schatzberg AF, Scully JH Jr, Kupfer DJ, Regier DA. Setting the record straight: a response to Dr Frances’ commentary on DSM-V. Psychiatr Times.2009;26(8):1-10.
• Frances A. A response to the charge of financial motivation. Psychiatr Times.2009;26(8):16.
• Carpenter WA. Criticism versus fact: a response to a warning sign on the road to DSM-V by Allen Frances, MD. http://www.psychiatrictimes.com/display/article/10168/1426935. Accessed November 23, 2009.
• Frances A. Dr Frances responds to Dr Carpen-ter: a sharp difference of opinion. http://www.psychiatrictimes.com/display/article/10168/1426935. Accessed November 23, 2009.
• Frances A. Advice to DSM-V . . . change deadlines and text, keep criteria stable. Psychiatr Times.2009;26(10):1-8.
• Frances A. Advice to DSM-V: integrate with ICD-11. Psychiatr Times.2009;26(11):22-23.


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • The Moral Struggles of Practicing Psychiatrists
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Grief and Depression: The Sages Knew the Difference
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • Will Your Clinical Records Support You in Court?
  • Refinements in ECT Techniques
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Ethical and Legal Issues in Geriatric Psychiatry
  • Eco-Psychiatry: Why We Need to Keep the Environment in Mind
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • Tie One On for Patients
  • NIMH vs DSM 5: No One Wins, Patients Lose
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
  • The Moral Struggles of Practicing Psychiatrists
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy